Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
ID: 352684Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/352684

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-157.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Addressing Health Inequities in Clinical Diagnostics" under the Small Business Technology Transfer Grants (R41/R42). This initiative aims to support Small Business Concerns (SBCs) in developing clinical diagnostics that specifically address health disparities affecting diverse patient populations, including racial and ethnic minorities and underserved communities. The program emphasizes the commercialization potential of proposed technologies and requires the involvement of health disparity populations throughout the development process. Applications are accepted until January 5, 2027, with no cost-sharing or matching requirements. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-157.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-157-Full-Announcement.html
    PAR-24-157.html
    The National Institutes of Health (NIH) is soliciting applications for the Addressing Health Inequities in Clinical Diagnostics funding opportunity (FON PAR-24-157) under the Small Business Technology Transfer Grants (R41/R42). This initiative seeks to support Small Business Concerns (SBCs) in developing clinical diagnostics that address health disparities prevalent among diverse patient populations. The goal is to innovate tools that improve equity in clinical laboratory assays and point-of-care devices, particularly for populations disproportionately affected by health inequities, including racial and ethnic minorities, individuals with disabilities, and underserved communities. Key components of this funding opportunity include an emphasis on the commercialization potential of proposed technologies, essential involvement of health disparity populations throughout the development process, and adherence to performance benchmarks for funding considerations. Applications are due at various intervals until 2027, and potential grantees must navigate a structured application and review process via Grants.gov, addressing NIH’s project requirements and compliance standards. This funding aims to foster innovative solutions that can effectively enhance health outcomes and reduce disparities in clinical settings.
    Similar Opportunities
    Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Addressing Health Inequities in Clinical Diagnostics" under the Small Business Innovation Research (SBIR) program (R43/R44). This initiative invites Small Business Concerns (SBCs) to develop improved clinical diagnostics that address health disparities caused by existing clinical laboratory assays and point-of-care devices, particularly those that do not adequately consider diverse patient populations. The program aims to foster advancements that enhance health outcomes for historically underrepresented groups by encouraging applicants to identify specific disparities and propose innovative solutions. Applications will be accepted starting March 5, 2024, with a close date of January 5, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-158.html.
    Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Small Business Technology Transfer (STTR) program, aimed at developing technologies to improve minority health and eliminate health disparities. Eligible applicants, specifically United States small business concerns (SBCs), are invited to submit grant applications for the R41/R42 program, which may include clinical trials, focusing on innovative solutions that are effective, affordable, and culturally acceptable for underserved populations. This initiative emphasizes the importance of addressing health inequities through technology, including disease self-management tools and mobile health solutions, with applications due by December 9, 2026. For further details, applicants can refer to the full announcement at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities," aimed at supporting U.S. small businesses in developing innovative technologies, products, or services that address health disparities among minority populations. Eligible applicants are encouraged to propose solutions that enhance healthcare delivery, promote health-seeking behaviors, and overcome barriers in minority health, with funding available through the Small Business Innovation Research (SBIR) program for both Phase I and II grants. This initiative underscores the government's commitment to advancing health equity and leveraging small business innovation to tackle significant healthcare challenges faced by underserved communities. Applications are due by December 10, 2026, and interested parties can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)" aimed at developing medical technologies that address health disparities among underserved populations in the U.S. This initiative encourages grant applications focused on creating effective, affordable, culturally acceptable, and accessible medical solutions, including devices, imaging systems, and telehealth innovations, while emphasizing the importance of formal collaborations with healthcare organizations serving these populations. The NIH plans to allocate approximately $2.4 million for this initiative, with an award ceiling of $500,000 per project, and expects to fund 3-4 awards over a project duration of up to four years. Interested applicants must submit their proposals by May 2, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    STTR Solutions to Enable Population Genomic Screening (R41/R42 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Small Business Technology Transfer (STTR) applications aimed at developing innovative solutions for population genomic screening, particularly for common genomic conditions in primary care settings. The initiative seeks to create technologies, services, and educational resources that address barriers to genomic screening, including management, awareness, and referral processes, while promoting community engagement and collaboration between primary care providers and specialized genomic centers. Eligible U.S.-based small businesses can apply for Phase I grants up to $400,000 and Phase II grants up to $2,150,000, with applications due by December 2, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-262.html.
    Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Community Level Interventions to Improve Minority Health and Reduce Health Disparities" (R01 - Clinical Trial Optional), aimed at supporting research that develops and tests community-level interventions to enhance minority health and mitigate health disparities. Applicants are encouraged to form collaborative partnerships with community organizations and must focus on innovative, sustainable initiatives that address health disparities through community-level determinants, employing a conceptual model to connect interventions with health outcomes. The grant provides up to $1 million in direct costs per year for a project duration of up to five years, with applications due by January 7, 2027. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-231.html.
    SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "SBIR Solutions to Enable Population Genomic Screening," aimed at soliciting Small Business Innovation Research (SBIR) grant applications from U.S. small businesses. The objective of this initiative is to develop innovative solutions that facilitate population genomic screening for common, actionable genomic conditions within primary care settings, addressing significant barriers such as logistical challenges, provider education, and follow-up procedures. This program is crucial for enhancing the readiness of primary care providers to manage genomic screening, particularly for conditions like hereditary breast cancer and Lynch syndrome. Grants of up to $400,000 are available for Phase I applications, with Phase II grants potentially reaching $2.15 million. Interested applicants should note that the submission window opens on November 1, 2024, with a deadline for applications set for December 2, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities," aimed at supporting intervention research to improve health outcomes among minority populations affected by health disparities. The initiative seeks projects that investigate the influence of structural racism and discrimination on health determinants, promote multidisciplinary collaboration, and utilize diverse data sources for comprehensive analysis. With a funding ceiling of $500,000, the application deadline is set for January 7, 2026, and interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity aimed at small business concerns (SBCs) to develop technologies that address health-related social needs impacting substance use disorders (SUD), excluding alcohol use disorder. This initiative, titled "Seeking Products to Address Social Needs impacting SUD," invites applications for Small Business Technology Transfer (STTR) grants under phases I and II, with a total funding amount of $1.3 million available for four awards in FY 2025. The focus is on leveraging innovative technologies, such as telemedicine and mobile health applications, to improve conditions like housing instability and food insecurity that influence SUD outcomes. Interested applicants must comply with specific eligibility criteria and application guidelines, with a submission deadline of March 13, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the full announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-047.html.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)" aimed at supporting Small Business Concerns (SBCs) in conducting investigator-initiated exploratory clinical trials related to neurological disorders. This initiative encourages applications for Phase I and II studies focusing on drugs, biologics, devices, and therapies that align with the mission of the National Institute of Neurological Disorders and Stroke (NINDS), emphasizing the inclusion of a Plan for Enhancing Diverse Perspectives (PEDP) to foster innovation. The maximum funding amounts are $295,924 for Phase I and $1,972,828 for Phase II projects, with applications required to demonstrate readiness for eventual FDA regulatory approval. Interested applicants can begin submitting proposals on December 5, 2023, with the application deadline set for September 5, 2026; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.